AUA 2020: Neoadjuvant Apalutamide + Radical Prostatectomy Show Promise in Organ-Confined Prostate Cancer
The agent was evaluated as neoadjuvant treatment in organ-confined disease for the first time.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.